David Krempa Biography and Net Worth

Chief Business Officer of Eton Pharmaceuticals

David is responsible for our business development, corporate strategy, and investor relations activities.

What is David Krempa's net worth?: The estimated net worth of David Krempa is at least $9.96 million as of June 13th, 2025. Mr. Krempa owns 622,869 shares of Eton Pharmaceuticals stock worth more than $9,955,938 as of December 16th. This net worth estimate does not reflect any other assets that Mr. Krempa may own. Additionally, Mr. Krempa receives a salary of $547,860.00 as Chief Business Officer at Eton Pharmaceuticals. Learn More about David Krempa's net worth.
How old is David Krempa?: Mr. Krempa is currently 35 years old. There are 2 older executives and no younger executives at Eton Pharmaceuticals. The oldest executive at Eton Pharmaceuticals is Mr. Sean E. Brynjelsen, President, CEO & Director, who is 52 years old. Learn More on David Krempa's age.
What is David Krempa's salary?: As the Chief Business Officer of Eton Pharmaceuticals, Inc., Mr. Krempa earns $547,860.00 per year. There are 2 executives that earn more than Mr. Krempa. The highest earning executive at Eton Pharmaceuticals is Mr. Sean E. Brynjelsen, President, CEO & Director, who commands a salary of $939,420.00 per year. Learn More on David Krempa's salary.
How do I contact David Krempa?: The corporate mailing address for Mr. Krempa and other Eton Pharmaceuticals executives is 21925 W. FIELD PARKWAY SUITE 235, DEER PARK IL, 60010. Eton Pharmaceuticals can also be reached via phone at (847) 787-7361 and via email at [email protected]. Learn More on David Krempa's contact information.
Has David Krempa been buying or selling shares of Eton Pharmaceuticals?: David Krempa has not been actively trading shares of Eton Pharmaceuticals over the course of the past ninety days. Most recently, David Krempa sold 10,223 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $14.73, for a transaction totalling $150,584.79. Following the completion of the sale, the insider now directly owns 612,646 shares of the company's stock, valued at $9,024,275.58. Learn More on David Krempa's trading history.
Who are Eton Pharmaceuticals' active insiders?: Eton Pharmaceuticals' insider roster includes Sean Brynjelsen (CEO), and David Krempa (Chief Business Officer). Learn More on Eton Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Eton Pharmaceuticals?: In the last year, insiders at the sold shares 5 times. They sold a total of 75,713 shares worth more than $1,178,031.37. The most recent insider tranaction occured on August, 20th when CFO James R Gruber sold 2,631 shares worth more than $42,148.62. Insiders at Eton Pharmaceuticals own 14.9% of the company. Learn More about insider trades at Eton Pharmaceuticals.
Information on this page was last updated on 8/20/2025.

David Krempa Insider Trading History at Eton Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/16/2025	Sell	10,223	$14.73	$150,584.79	612,646
6/13/2025	Sell	6,800	$14.77	$100,436.00	622,869
6/12/2025	Sell	16,977	$14.92	$253,296.84	629,669

David Krempa Buying and Selling Activity at Eton Pharmaceuticals

Eton Pharmaceuticals Company Overview

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Today's Range

Now: $15.95

$15.75

$16.39

50 Day Range

MA: $17.60

$15.37

$21.15

2 Week Range

Now: $15.95

$11.09

$23.00

Volume

250,074 shs

Average Volume

341,126 shs

Market Capitalization

$427.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.17

David Krempa Biography and Net Worth

What is David Krempa's net worth?

How old is David Krempa?

What is David Krempa's salary?

How do I contact David Krempa?

Has David Krempa been buying or selling shares of Eton Pharmaceuticals?

Who are Eton Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Eton Pharmaceuticals?